|
Clinical background data |
|||
| AUDS patients |
MDE patients |
p-value |
|
|
|
|||
| n = 16 |
N = 16 |
||
|
|
|||
| Agea |
32.1 (11.4, 19–58) |
32.8 (13.0, 18–62) |
0.99e |
|
|
|||
| Gender (men) |
6 (38%) |
6 (38%) |
1.00f |
|
|
|||
| Neuroleptic medicationg |
13 (81%) |
14 (88%) |
1.00f |
|
|
|||
| Anti-epileptic medication |
11 (62.5%) |
1 (6.25%) |
0.001f |
|
|
|||
| Alcohol abuseb |
4 (27%)c |
4 (31%)d |
1.00f |
|
|
|||
| Drowsiness |
11 (69%) |
11 (69%) |
1.00f |
|
Number of subjects (%) a Mean (SD, range) b The Alcohol Use Disorders Identification Test (AUDIT) ≥ 8 cn = 15 dn = 13 eMann-Whitney test fFisher exact test g anti-depressive and anti-psychotic medication AUDS: Acute Unstable Depressive Syndrome. MDE: Major Depressive Episode | |||
Bjørk et al. BMC Psychiatry 2008 8:89 doi:10.1186/1471-244X-8-89 |
|||